AOM treatment up-regulated VEGF-A in all of the RAS modulation groups: 2.8-fold in the AOM alone group compared to 2.7-fold in the AOM + AngII group, and 1.5-fold in the AOM + Losartan group (Fig. 2a). The gene discussed is VEGFA; the disease is infectious otitis media.